← Leaderboards
Claudia Marcela Diaz-Montero
University Of Miami School Of Medicine
$3,273,128
Attributed
$4,704,129
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,704,129 · 5
By mechanism
R01$2,146,502 · 1
U54$1,533,775 · 2
K01$644,640 · 1
R21$379,212 · 1
Top collaborators
- Alok A Khorana3 shared
- Keith R. Mccrae3 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Savita Pahwa$35,297,534
- Victor L Perez$8,283,705
- Thomas R Malek$20,207,638
- Robert Benjamin Levy$11,045,297
- Bonnie B. Blomberg$9,109,784
Others in their field
Top investigators on “Generations”
- Richard A Gibbs · Baylor College Of Medicine$539,942,150
- David Heimbrook · Leidos Biomedical Research, Inc.$461,253,475
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Kiran Datta · Leidos Biomedical Research, Inc.$292,634,066
- Dennis R. Burton · Scripps Research Institute$280,469,869
- Eric S Lander · Whitehead Institute For Biomedical Res$262,517,055
Research focus
GenerationsCellsImmunotherapyT-LymphocyteLaboratoriesTumorResponseImmuneProgramsPathway InteractionsPlasmaImmunophenotypingSamplingReportingIn VitroCancer TherapyBaseCytokineCancer ImmunotherapyCharacteristicsCell TherapyAntigensCd8b1 GeneEnvironment
Grant awards (15)
Mechanisms of cancer immunotherapy-associated thrombosis$720,736
R01 · FY2025 · HL
Translational and Clinical Trial Correlates Core$292,346
U54 · FY2025 · CA · contact PI
Mechanisms of cancer immunotherapy-associated thrombosis$704,368
R01 · FY2024 · HL
Translational and Clinical Trial Correlates Core$488,827
U54 · FY2024 · CA · contact PI
Mechanisms of cancer immunotherapy-associated thrombosis$721,398
R01 · FY2023 · HL
Translational and Clinical Trial Correlates Core$298,207
U54 · FY2023 · CA · contact PI
Translational and Clinical Trial Correlates Core$454,395
U54 · FY2022 · CA · contact PI
Improving adoptive cell therapy by enhancing T cell longevity$172,369
R21 · FY2016 · CA · contact PI
Improving adoptive cell therapy by enhancing T cell longevity$206,843
R21 · FY2015 · CA · contact PI
Programming T Cells for Successful Adoptive Cell Therapy$130,627
K01 · FY2013 · CA · contact PI
Programming T Cells for Successful Adoptive Cell Therapy$1
K01 · FY2013 · CA · contact PI
Programming T Cells for Successful Adoptive Cell Therapy$130,628
K01 · FY2012 · CA · contact PI
Programming T Cells for Successful Adoptive Cell Therapy$130,628
K01 · FY2011 · CA · contact PI
Programming T Cells for Successful Adoptive Cell Therapy$127,767
K01 · FY2010 · CA · contact PI
Programming T Cells for Successful Adoptive Cell Therapy$124,989
K01 · FY2009 · CA · contact PI